120 related articles for article (PubMed ID: 14523477)
1. Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience.
Abbott BL; Rubnitz JE; Tong X; Srivastava DK; Pui CH; Ribeiro RC; Razzouk BI
Leukemia; 2003 Nov; 17(11):2090-6. PubMed ID: 14523477
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group.
; te Loo DM; Kamps WA; van der Does-van den Berg A; van Wering ER; de Graaf SS
J Clin Oncol; 2006 May; 24(15):2332-6. PubMed ID: 16710032
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture.
Bürger B; Zimmermann M; Mann G; Kühl J; Löning L; Riehm H; Reiter A; Schrappe M
J Clin Oncol; 2003 Jan; 21(2):184-8. PubMed ID: 12525508
[TBL] [Abstract][Full Text] [Related]
4. Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis?
Jastaniah W; Elimam N; Abdalla K; Khattab TM; Felimban S; Abrar MB
Hematology; 2015 Dec; 20(10):561-6. PubMed ID: 26010408
[TBL] [Abstract][Full Text] [Related]
5. Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
Winick N; Devidas M; Chen S; Maloney K; Larsen E; Mattano L; Borowitz MJ; Carroll A; Gastier-Foster JM; Heerema NA; Willman C; Wood B; Loh ML; Raetz E; Hunger SP; Carroll WL
J Clin Oncol; 2017 Aug; 35(22):2527-2534. PubMed ID: 28535084
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia.
Levinsen M; Taskinen M; Abrahamsson J; Forestier E; Frandsen TL; Harila-Saari A; Heyman M; Jonsson OG; Lähteenmäki PM; Lausen B; Vaitkevičienė G; Asberg A; Schmiegelow K;
Pediatr Blood Cancer; 2014 Aug; 61(8):1416-21. PubMed ID: 24623619
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
J Clin Oncol; 2005 Dec; 23(36):9172-8. PubMed ID: 16361619
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of central nervous system involvement at diagnosis of childhood T-cell acute lymphoblastic leukemia.
Jaing TH; Yang CP; Hung IJ; Tsay PK; Tseng CK; Chen SH
Pediatr Blood Cancer; 2005 Aug; 45(2):135-8. PubMed ID: 15704218
[TBL] [Abstract][Full Text] [Related]
9. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.
Mahmoud HH; Rivera GK; Hancock ML; Krance RA; Kun LE; Behm FG; Ribeiro RC; Sandlund JT; Crist WM; Pui CH
N Engl J Med; 1993 Jul; 329(5):314-9. PubMed ID: 8321259
[TBL] [Abstract][Full Text] [Related]
10. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
[TBL] [Abstract][Full Text] [Related]
11. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
[TBL] [Abstract][Full Text] [Related]
13. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
Pediatr Blood Cancer; 2010 Sep; 55(3):414-20. PubMed ID: 20658610
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system disease in pediatric acute myeloid leukemia: A report from the Children's Oncology Group.
Johnston DL; Alonzo TA; Gerbing RB; Aplenc R; Woods WG; Meshinchi S; Gamis AS
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28453910
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
Marcucci G; Mrózek K; Ruppert AS; Maharry K; Kolitz JE; Moore JO; Mayer RJ; Pettenati MJ; Powell BL; Edwards CG; Sterling LJ; Vardiman JW; Schiffer CA; Carroll AJ; Larson RA; Bloomfield CD
J Clin Oncol; 2005 Aug; 23(24):5705-17. PubMed ID: 16110030
[TBL] [Abstract][Full Text] [Related]
16. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
17. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia.
Kobayashi R; Tawa A; Hanada R; Horibe K; Tsuchida M; Tsukimoto I;
Pediatr Blood Cancer; 2007 Apr; 48(4):393-8. PubMed ID: 16550530
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia.
Roberson JR; Onciu M; Pounds S; Rubnitz JE; Pui CH; Razzouk BI
Pediatr Blood Cancer; 2008 Mar; 50(3):542-8. PubMed ID: 17763467
[TBL] [Abstract][Full Text] [Related]
19. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.
Schlenk RF; Benner A; Krauter J; Büchner T; Sauerland C; Ehninger G; Schaich M; Mohr B; Niederwieser D; Krahl R; Pasold R; Döhner K; Ganser A; Döhner H; Heil G
J Clin Oncol; 2004 Sep; 22(18):3741-50. PubMed ID: 15289486
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
